Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission.
Breuer
Judith
J
D000336:Aerosols / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use; D002644:Chickenpox / Q000276:immunology / Q000635:transmission*; D019433:Chickenpox Vaccine / Q000276:immunology* / Q000627:therapeutic use; D003428:Cross Infection / Q000517:prevention & control / Q000635:transmission*; D004279:DNA, Viral / Q000302:isolation & purification; D006562:Herpes Zoster / Q000188:drug therapy / Q000635:transmission*; D014645:Herpesvirus 3, Human / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D012463:Saliva / Q000821:virology
D000336:Aerosols; D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D004279:DNA, Viral